Endogenous

内源性

基本信息

  • 批准号:
    01480247
  • 负责人:
  • 金额:
    $ 4.22万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1989
  • 资助国家:
    日本
  • 起止时间:
    1989 至 1991
  • 项目状态:
    已结题

项目摘要

Endogenous digitalis-like factor (EDLF) is thought to be one of the causal factor for the development of essential hypertension although the precise nature of the factor is not clear. In the present study, we investigated about the participation of circulating EDLF in the development of hypertension, and partially purified the EDLF. Circulating level of the EDLF was measured by radioimmuno assay using anti-oubain monoclonal antibody. The plasma level of EDLF was increased in patients with essential hypertension compared to that in normal subjects. The level was significantly decreased by sodium depletion, and significantly increased with high salt diet in patients with essential hypertension, and was significantly decreased after adrenectomy in a patient with primary aldosteronism. 1 The EDLF was partially purified from, plasma from patients with essential hypertension. Lipid fraction extracted from the plasma by methanol/chloroform was applied to high-performance liquid chromatogrhy with CLC-CN, column and HCG-15SH column. The molecular weight of the partially, purified EDLF. was about 600. We also developed a monoclonal antibody to oubain, which recognized lacton ring and trans-cis structuring of the BCD rings.
内源性洋地黄样因子(EDLF)被认为是原发性高血压发生发展的原因之一,尽管该因子的确切性质尚不清楚。本研究探讨了循环中EDLF在高血压发生发展中的作用,并对EDLF进行了部分纯化。采用放射免疫法测定EDLF水平。原发性高血压患者血浆EDLF水平明显高于正常人。钠耗竭后该水平显著降低,原发性高血压患者高盐饮食后该水平显著升高,原发性醛固酮增多症患者肾上腺切除术后该水平显著降低。1从原发性高血压患者血浆中部分纯化EDLF。用甲醇/氯仿提取血浆中的脂质组分,用高效液相色谱法,以CLC-CN柱和HCG-15 SH柱进行分离。部分纯化的EDLF的分子量。大约是600。我们还开发了一种单克隆抗体,识别内酯环和BCD环的反式-顺式结构。

项目成果

期刊论文数量(74)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ogihara Toshio,et al.: "Changes in plasma renin activity and aldosterone concentration in response to endothelin injection in dogs." Acta Endocrinologica. 121. 5685-5689 (1989)
Ogihara Toshio 等人:“狗内皮素注射后血浆肾素活性和醛固酮浓度的变化。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
荻原 俊男ら: "ウアバイン様ナトリウム利尿因子" 日本臨床代謝学会記録. 27. 18-19 (1991)
Toshio Ogihara 等:“Ouabain 样利尿钠因子”日本临床代谢学会记录 27. 18-19 (1991)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ogihara T, Morimoto S and Tabuchi Y.: "The role of endothelin in blood pressure regulation" In Peptide Regulation of Cardiovascular Function. Ed. by Imura H., Academic Press Inc.259-272 (1991)
Ogihara T、Morimoto S 和 Tabuchi Y.:“内皮素在血压调节中的作用”,心血管功能的肽调节。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ogihara Toshio,et al.: "Effect of ouabain on hemodynamics in acute volume expanded hypertensive dogs." Basic Research in Cardiology. 84. 319-325 (1989)
Ogihara Toshio 等人:“哇巴因对急性容量扩张高血压犬血流动力学的影响。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ogihara T, Morita R, Morimoto S, Imanaka S and Fukuo K.: "Intracellular signal transduction evoked by low-density lipoprotein in vascular smooth muscle cells." In Calcium-regulating Hormones. I. Role in Disease and Aging. 90. 116-121 (1991)
Ogihara T、Morita R、Morimoto S、Imanaka S 和 Fukuo K.:“血管平滑肌细胞中低密度脂蛋白引起的细胞内信号转导。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OGIHARA Toshio其他文献

OGIHARA Toshio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OGIHARA Toshio', 18)}}的其他基金

Identification of the susceptible gene responsible for essential hypertension and establishment of tailored medicine
原发性高血压易感基因的鉴定及个体化药物的建立
  • 批准号:
    14207035
  • 财政年份:
    2002
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Identification of genetic factors responsible for the pathogenesis of essential hypertension
原发性高血压发病机制遗传因素的鉴定
  • 批准号:
    13204050
  • 财政年份:
    2001
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Identification of genetic susceptibility for cardiovascular disease : two large genetic epidemiological study with cohort base
心血管疾病遗传易感性的识别:两项大型队列基础遗传流行病学研究
  • 批准号:
    10307018
  • 财政年份:
    1998
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A).
Gene Therapy in the Cardiovascular Disease
心血管疾病的基因治疗
  • 批准号:
    09044299
  • 财政年份:
    1997
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Gene analysis of hypertension and development of new therapy
高血压基因分析及新疗法开发
  • 批准号:
    07407021
  • 财政年份:
    1995
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular Research of the Etiology and Treatment of Hypertension
高血压病因及治疗的分子研究
  • 批准号:
    04404044
  • 财政年份:
    1992
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
Pathogenesis of hypertension and interraction of vasoactive hormones
高血压的发病机制与血管活性激素的相互作用
  • 批准号:
    60480270
  • 财政年份:
    1985
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Effects of the Atrial Natriuretic Factor enhancer and the 5'HS4 insulator on the probability of gene expression.
心房钠尿因子增强子和 5HS4 绝缘子对基因表达概率的影响。
  • 批准号:
    nhmrc : 109003
  • 财政年份:
    2000
  • 资助金额:
    $ 4.22万
  • 项目类别:
    NHMRC Project Grants
CIS ACTNG REG ELEMENT: ATRIAL NATRIURETIC FACTOR GENE IN ACUTE PRESSURE OVERLOAD
CIS ACTNG 调节元件:急性压力超负荷时的心房利尿钠因子基因
  • 批准号:
    6277848
  • 财政年份:
    1998
  • 资助金额:
    $ 4.22万
  • 项目类别:
CONTROLLED RELEASE OF ATRIAL NATRIURETIC FACTOR
心房钠尿因子的受控释放
  • 批准号:
    6388410
  • 财政年份:
    1997
  • 资助金额:
    $ 4.22万
  • 项目类别:
CONTROLLED RELEASE OF ATRIAL NATRIURETIC FACTOR
心房钠尿因子的受控释放
  • 批准号:
    2027212
  • 财政年份:
    1997
  • 资助金额:
    $ 4.22万
  • 项目类别:
CONTROLLED RELEASE OF ATRIAL NATRIURETIC FACTOR
心房钠尿因子的受控释放
  • 批准号:
    2900983
  • 财政年份:
    1997
  • 资助金额:
    $ 4.22万
  • 项目类别:
CONTROLLED RELEASE OF ATRIAL NATRIURETIC FACTOR
心房钠尿因子的受控释放
  • 批准号:
    6181904
  • 财政年份:
    1997
  • 资助金额:
    $ 4.22万
  • 项目类别:
CONTROLLED RELEASE OF ATRIAL NATRIURETIC FACTOR
心房钠尿因子的受控释放
  • 批准号:
    2685225
  • 财政年份:
    1997
  • 资助金额:
    $ 4.22万
  • 项目类别:
BIOLOGY OF ATRIAL NATRIURETIC FACTOR AND ITS RECEPTORS
心房利尿钠因子及其受体的生物学
  • 批准号:
    2468848
  • 财政年份:
    1994
  • 资助金额:
    $ 4.22万
  • 项目类别:
BIOLOGY OF ATRIAL NATRIURETIC FACTOR AND ITS RECEPTORS
心房利尿钠因子及其受体的生物学
  • 批准号:
    2749641
  • 财政年份:
    1994
  • 资助金额:
    $ 4.22万
  • 项目类别:
BIOLOGY OF ATRIAL NATRIURETIC FACTOR AND ITS RECEPTORS
心房利尿钠因子及其受体的生物学
  • 批准号:
    2227348
  • 财政年份:
    1994
  • 资助金额:
    $ 4.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了